0001209191-11-058411.txt : 20111129 0001209191-11-058411.hdr.sgml : 20111129 20111129211334 ACCESSION NUMBER: 0001209191-11-058411 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111128 FILED AS OF DATE: 20111129 DATE AS OF CHANGE: 20111129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MANHARD KIMBERLY CENTRAL INDEX KEY: 0001202094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33734 FILM NUMBER: 111232539 MAIL ADDRESS: STREET 1: C/O ARDEA BIOSCIENCES, INC. STREET 2: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE CENTRAL INDEX KEY: 0001103390 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943200380 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-652-6500 MAIL ADDRESS: STREET 1: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE DATE OF NAME CHANGE: 20000127 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-11-28 0 0001103390 Ardea Biosciences, Inc./DE RDEA 0001202094 MANHARD KIMBERLY 4939 DIRECTORS PLACE SAN DIEGO CA 92121 0 1 0 0 SVP, Regulatory & Dev Ops Common Stock 2011-11-28 4 M 0 5000 3.90 A 14731 D Common Stock 2011-11-28 4 S 0 5000 17.6714 D 9731 D Employee Stock Option (Right to Buy) 3.90 2011-11-28 4 M 0 5000 0.00 D 2016-12-20 Common Stock 5000 35000 D The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 22, 2011. Includes 344 shares acquired under the Ardea Biosciences, Inc. 2000 Employee Stock Purchase Plan on November 14, 2011. The range of sales prices received was $17.06 to $17.92. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. 25% of the shares subject to the stock option vested and became exercisable on December 21, 2007. The remaining shares vest in equal monthly installments over the following 3 years. /s/ Kimberly J. Manhard 2011-11-29